Cigarette smoking is a well documented additive risk factor for emphysema development. Background -Severe 1 -antitrypsin (AAT) deficiency (PiZZ) is associated with an in-It has been suggested that other genetic and/ or environmental factors such as previous lower creased risk of lung emphysema, especially in smokers. The aim of this study was to respiratory tract infections may predispose to emphysema.
of AAT deficiency was started in August 1991 cording and reported that they had never smoked regularly. Of the 257 non-smokers in with the aim of including all individuals aged 18 years or over with severe AAT deficiency the register 25 were younger than 20 years, and in seven cases no FEV 1 recording was (PiZZ, Z0 and 00) living in Sweden. After establishing a definite diagnosis of AAT de-available. Thus, the study group consisted of 225 individuals (107 men). The data reported ficiency, attending physicians invite the patients (residents in different counties throughout to the register at enrolment were used in the analyses. Sweden) to be included in the register. Clinical examination, blood samples, and lung function Plasma AAT concentrations were measured by radioimmunoassay 9 and Pi phenotypes detests are performed at the patients' local hospitals, the results being reported to the registry termined by isoelectric focusing. 10 The indications for plasma protein analysis in a yearly questionnaire. The questionnaire consists of two parts: one to be answered by the leading to PiZZ diagnosis were respiratory disease or symptoms including repeated resattending physician, the other by the patient.
Physicians report the following data: (a) piratory tract infections in 65 cases (29%, "lung disease"), other clinical symptoms in 103 cases characteristics of the patient (sex, date of birth (and death if applicable)); (b) indication(s) for (46%, "other disease"), family study or screening in 53 cases (23%, "screening"), and unthe original plasma protein analysis; (c) type of lung or other disease; (d) date of last chest known in four cases (2%). These subgroups are referred to as "indication subgroups". radiograph; (e) results of serum transferase measurements; (f) results of current and/or
The indication subgroup "other disease" consisted of hepatic (13 cases), renal (nine older spirometric investigations; (g) treatment for pulmonary disease (including replacement cases), joint symptoms (13 cases), repeated infections other than in the respiratory tract therapy with human AAT); (h) treatment for other diseases; and (i) liver or lung trans-(27 cases), high sedimentation rate (nine cases), and other symptoms (32 cases). Of plantation.
The patient questionnaire is a modified ver-the 53 individuals in the indication subgroup "screening" 34 were identified by family studies sion of the adult respiratory disease questionnaire used in epidemiological research. 8 and 19 by different screening procedures including newborn infants, 11 school children, and The following questions are included: (a) number of siblings; (b) number of siblings tested blood donors. The PiZZ diagnosis was established 0-28 years before the inclusion, the for AAT deficiency; (c) smoking habits until inclusion in the register ("have you ever reg-exact date being unknown in some cases.
All patients gave their informed consent to ularly smoked?" yes/no; if yes, age at starting, age at stopping and average daily consumption participate in the study which was approved by the ethics committee of the Medical Faculty of (number cigarettes/cigars or grams of pipe tobacco)); (d) occupation; (e) current em-the University of Lund. ployment status; (f) occupational exposure to gas, fumes, or dust for at least three months (yes/no; if yes, duration of exposure in years); (g) annual frequency of colds (Ζ1 or [2);    (h) number of attacks of pneumonia prior to Standard spirometric tests had been performed inclusion in the register; (i) cough and phlegm for each subject at either the physiological (yes/no); (j) occurrence of daily cough or laboratory or the lung department of his/her phlegm for at least three months per year; (k) local hospital. The best of three measurements wheeziness (yes/no; if yes, with colds, damp of FEV 1 and vital capacity (VC) were recorded, weather, on exertion, other occasions); (l) and in 41% of the cases recordings were also shortness of breath on exertion; (m) duration performed after inhalation of a 2 agonist. The (years) of above symptoms; (n) visual analogue results of the spirometric tests are expressed as scales for self-rating of general health and of percentages of predicted values according to the capacity for physical exercise.
reference values of Berglund and coworkers.
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The follow up period for each individual registered is planned to be at least five years. In December 1994 the total number of patients included was 665, the mean age (range) being 48 (18-89) years at inclusion. Seventy five   The Student's t test and analysis of variance (11%) were current smokers, 333 (50%) exsmokers, and 257 (39%) never smokers. The were used to compare the continuous variables between the groups. The Tukey honest sigannual increment of new patients to the register is approximately 100, and the refusal rate only nificant difference (HSD) test for unequal sample sizes was used for multiple com-5%. parisons 13 and the 2 test was used to compare the categorical variables. The independent effects of sex, age, AAT levels, pneumonia,  This cross sectional study is based on those wheeziness, and occupational exposure, and the statistical significance of interactions bePiZZ individuals aged more than 20 years included in the Swedish AAT deficiency register tween these effects in determining percentage predicted FEV 1 , were established by multiple up to December 1994 who, at the time of enrolment in the register, had a forced ex-linear regression. A p value of <0.05 was considered significant. piratory volume in one second (FEV 1 ) regroup.bmj.com on May 4, 2017 -Published by http://thorax.bmj.com/ Downloaded from giving a reversibility of 80%. In 12 other cases (0.5-6.0) l before and 2.8 (0.6-6.1) l after inhalation of a 2 agonist, the mean (range) reversibility being 6 (0-80)%. FEV 1 increased      from 0.5 to 0.9 litres in one exceptional patient,    The male/female ratio was 35/30 in the "lung disease" subgroup, 42/61 in the "other disease" subgroup, and 27/26 in the "screening" indication subgroup (p=0.207, 2 test), the mean (range) ages of the three subgroups were 62 (20-89) years, 46 (20-87) years, and 36 (20-61) years, respectively, and the mean (SD) FEV 1 was 61 (29), 92 (22), and 99 (15)% predicted, respectively. When adjusted for age there was a significant difference in lung function between the "lung disease" and the "other disease" subgroups (p<0.001). The "screening" subgroup was excluded from the test because the mean age was only 36 years and the maximum age 61 years.
Before analysing lung function by age, each indication subgroup was split up into three age groups (<50, 50-64, and >64 years) (fig 2) . In the "screening" subgroup only age groups <50 
Figure 1 FEV 1 (% predicted) versus age in PiZZ men (n=107) and women (n=118)
(% predicted) was significantly higher in the who had never smoked.
<50 years age group than in the 50-64 age group in the "lung disease" subgroup (p= 0.004) and in the "other disease" subgroup (p=0.013), whereas the difference in the "screening" subgroup was not significant (p= 0.618).
    
Eleven subjects recorded their occupation as house wife, four were students, and all the other individuals were or had been employed.
Occupational exposure to gas, fumes, or dust for at least three months was reported by 85 individuals (38%, "exposed"), denied by 130 individuals (58%, "non-exposed"), and 10 individuals (4%) did not know.
More of the men than the women reported occupational exposure to airway irritants (52% (% predicted) (26) 78 (29) 87 (22) 81 (21) dependent factor influencing FEV 1 (p=0.008), * p=0.032 compared with non-exposed group aged [50 years (Student's t test).
whereas in men both increasing age (p<0.001) †p=0.017 compared with non-exposed women (Tukey HSD test).
and wheeziness (p=0.009) had an independent effect on FEV 1 . In the "lung disease" indication subgroup in the "screening" subgroup (42% versus 28%) increasing age (p=0.022) was the independent but the difference was not significant (p= factor influencing FEV 1 (% predicted), while 0.285).
in the other indication subgroups none of the For the whole population and those below above factors had an independent effect on 50 years of age lung function did not differ lung function. significantly between the "exposed" and "nonexposed" groups. In contrast, in those aged 50 years and above FEV 1 (% predicted) was lower in individuals "exposed" than in those "non-  exposed" to airway irritants (p=0.032, table Forty five percent of individuals reported hav-2). Lung function did not differ significantly ing had one or more attacks of pneumonia between the men and women in the "exposed" before inclusion in the register. Breathlessness and "non-exposed" groups with the exception at exertion was reported by 46% and wheezof "non-exposed" women and "exposed" men iness by 39%. The mean age at onset of breathin the older age group (p=0.017, table 2). lessness was 52 years and of wheeziness was Among the "exposed" individuals the median 45 years. Medical history or symptoms did not duration of exposure was eight years (range differ between the sexes. 1-50) with no difference between the sexes, Wheeziness was reported by 46% of inbut the duration of exposure was correlated dividuals exposed to airway irritants and 34% with age (r=0.50, p<0.001). Linear regression of those not exposed (p=0.071). A history of analysis showed significant correlation between pneumonia was reported by 54% of individuals FEV 1 (% predicted) and duration of exposure in the "lung disease" subgroup, 55% in the to irritants (p<0.001), a correlation which dis-"other disease" subgroup, and 11% in the appeared when correction was made for age.
"screening" indication subgroup (p<0.001).
Shortness of breath at exertion was reported by 85%, 35%, and 23%, respectively (p<0.001)     and wheezing by 63%, 35%, and 17%, reIn multiple linear regression analysis FEV 1 (% spectively (p<0.001). predicted) was used as the dependent variable with sex, age, plasma AAT level, history of pneumonia, wheeziness, and occupational exposure to irritants as the independent variables. Discussion
In patients with AAT deficiency cigarette smokThe results are shown in table 3. Increasing age (p<0.001), male sex (p=0.001), and symp-ing is a well documented additional risk factor for emphysema. 2 The aim of our study was to toms of wheezing (p=0.007) were identified as the independent determinants of FEV 1 .
analyse lung function in PiZZ individuals who had never smoked, thus eliminating smoking An identical analysis was then performed in the two age groups (<50 and [50 years). In as a confounding factor. As in previously published studies, most of the patients (77%) were the younger age group only male sex was a determinant of lung function (p=0.028), but identified because of some disease, but in contrast to several other studies 2 14 15 only 29% were in the older group male sex (p=0.025), wheeziness (p=0.011), and occupational exposure identified because of lung disease. 
